Role of spectral presaturation attenuated inversion-recovery fat-suppressed T2-weighted MR imaging in active inflammatory bowel disease

Journal of Magnetic Resonance Imaging

Volumn 28, Issue 5, 2008, Pages 1133-1140

  Udayasankar, Unni K ^a   Martin, Diego ^a   Lauenstein, Thomas ^a   Rutherford, Robin ^a   Galloway, John ^a   Tudorascu, Dana ^a   Sitaraman, Shanthi V ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Active disease; Crohn's disease; Small bowel MRI; SPAIR

Indexed keywords

GADODIAMIDE;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; ENTERITIS; FEMALE; FOURIER TRANSFORMATION; HUMAN; INTERMETHOD COMPARISON; INTESTINAL FIBROSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS;

ADIPOSE TISSUE; ADULT; AGED; ALGORITHMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; INFLAMMATORY BOWEL DISEASES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 55749098757     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21574     Document Type: Article

References (26)

1. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-444.
2. Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 1989;30:983-989.
3. Mako EK, Mester AR, Tarjan Z, Karlinger K, Toth G. Enteroclysis and spiral CT examination in diagnosis and evaluation of small bowel Crohn's disease. Eur J Radiol 2000;35:168-175.
4. Miao YM, Koh DM, Amin Z, et al. Ultrasound and magnetic resonance imaging assessmentof active bowel segments in Crohn's disease. Clin Radiol 2002;57:913-918.
5. Erber WF, Erber JA. Meta-analysis of the yield of capsule endoscopy in patients with Crohn's disease. Am J Gastroenterol 2006; 101:2669.
6. Masselli G, Casciani E, Polettini E, Lanciotti S, Bertini L, Gualdi G. Assessment of Crohn's disease in the small bowel: prospective comparison of magnetic resonance enteroclysis with conventional enteroclysis. Eur Radiol 2006;16:2817-2827.
7. Florie J, Wasser MN, Arts-Cieslik K, Akkerman EM, Siersema PD, Stoker J. Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn's disease. AJR Am J Roentgenol 2006;186:1384-1392.
8. Maccioni F, Bruni A, Viscido A, et al. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 2006;238:517-530.
9. Ajaj WM, Lauenstein TC, Pelster G, et al. Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity. Gut 2005;54:257-263.
10. Lauenstein TC, Schneemann H, Vogt FM, Herborn CU, Ruhm SG, Debatin JF. Optimization of oral contrast agents for MR imaging of the small bowel. Radiology 2003;228:279-283.
11. Papanikolaou N, Prassopoulos P, Grammatikakis I, Maris T, Gourtsoyiannis NC. Technical challenges and clinical applications of magnetic resonance enteroclysis. Top Magn Reson Imaging 2002; 13:397-408.
12. Kugathasan S, Werlin SL, Martinez A, Rivera MT, Heikenen JB, Binion DG. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease. Am J Gastroenterol 2000; 95:3189-3194.
13. Rutgeerts P, Diamond RH, Bala M, et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc 2006;63:433-442; quiz 464.
14. D'Haens G, Van Deventer S, Van Hogezand R, et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: a European multicenter trial. Gastroenterology 1999;116:1029-1034.
15. Martin DR, Danrad R, Herrmann K, Semelka RC, Hussain SM. Magnetic resonance imaging of the gastrointestinal tract. Top Magn Reson Imaging 2005;16:77-98.
16. Chung JJ, Semelka RC, Martin DR, Marcos HB. Colon diseases: MR evaluation using combined T2-weighted single-shot echo train spin-echo and gadolinium-enhanced spoiled gradient-echo sequences. J Magn Reson Imaging 2000;12:297-305.
17. Narin B, Ajaj W, Gohde S, et al. Combined small and large bowel MR imaging in patients with Crohn's disease: a feasibility study. Eur Radiol 2004;14:1535-1542.
18. Prassopoulos P, Papanikolaou N, Grammatikakis J, Rousomoustakaki M, Maris T, Gourtsoyiannis N. MR enteroclysis imaging of Crohn disease. Radiographics 2001;21(Spec No):S161-172.
19. Schunk K. Small bowel magnetic resonance imaging for inflammatory bowel disease. Top Magn Reson Imaging 2002;13:409-425.
20. Ott DJ. MR imaging of Crohn's disease: what is the attraction? Am J Gastroenterol 2003;98:211-212.
21. Ochsenkuhn T, Herrmann K, Schoenberg SO, Reiser MF, Goke B, Sackmann M. Crohn disease of the small bowel proximal to the terminal ileum: detection by MR-enteroclysis. Scand J Gastroenterol 2004;39:953-960.
22. Horsthuis K, Lavini Mphil C, Stoker J. MRI in Crohn's disease. J Magn Reson Imaging 2005;22:1-12.
23. Rottgen R, Herzog H, Lopez-Haninnen E, Felix R. Bowel wall enhancement in magnetic resonance colonography for assessing activity in Crohn's disease. Clin Imaging 2006;30:27-31.
24. Wiarda BM, Kuipers EJ, Heitbrink MA, van Oijen A, Stoker J. MR Enteroclysis of inflammatory small-bowel diseases. AJR Am J Roentgenol 2006;187:522-531.
25. Koh DM, Miao Y, Chinn RJ, et al. MR imaging evaluation of the activity of Crohn's disease. AJR Am J Roentgenol 2001;177:1325-1332.
26. Low RN, Francis IR, Politoske D, Bennett M. Crohn's disease evaluation: comparison of contrast-enhanced MR imaging and single-phase helical CT scanning. J Magn Reson Imaging 2000;11:127-135.